Hematology

For information on the following Clinical Trials, please contact the
Hematology, Oncology and Stem Cell Transplantation Department
at 773-880-4562 during 8:30 AM to 5:00 PM Central Standard Time.

 

Hemophilia  Investigator 
Mechanisims of Race-Bsed Differences in factor VIII Immunogenicity in Hemophilia Alexis Thompson, MD
Maintaining a Patient Database at a Centralized Server through American Thrombosis and Hemostasis Network    Anjali Sharathkumar, MD
   
ITP and Platelet Disorders  Investigator 
A Phase 3 Randomized, Double Blind, Placebo Controlled Study to Determine the Safety and Efficacy of Romiplostim in Thrombocytopenic Pediatric Subjects with Immune Thrombocytopenia (ITP)   Alexis Thompson, MD
 Eltrombopag PETIT: Eltrombopag in Pediatric patients with Thrombocytopenia from ITP  Alexis Thompson, MD
   

Sickle Cell 

 Investigator 

Evaluation of Free-Living Physical Activity and Its Relationship to Exercise Capacity in Children and Adolescents with Sickle Cell Anemia

 Robert Liem, MD
Silent Infarct Transfusion Trial in Sickle Cell Patients (SITT)  Alexis Thompson, MD
The Physiologic Assessment of Exercise Capacity in Pediatric Sickle Cell Anemia Robert Liem, MD
Pharmacokinetics and Relative Bioavailability of a Liquid Formulation of Hydroxyurea in Pediatric Patients with Sickle Cell Anemia  Robert Liem, MD
Intravenous Magnesium for Sickle Cell Vasoocclusive Crisis (Magnesium in Crisis (MAGIC))  Robert Liem, MD
Longitudinal Changes in Exercise Capacity in Children and Young Adults with Sickle Cell Anemia   Robert Liem, MD
The Detection of Lower Airway Airflow Obstruction by Impulse Oscillometry in Children with Sickle Cell Disease  Robert Liem, MD
Modulation of Iron Deposition in Sickle Cell Disease and Other Hemoglobinopathies (MCSIO): Survey Study  Alexis Thompson, MD
An Open-Label, Dose-Ranging Study of Prasugrel in Pediatric Patients with Sickle Cell Disease  Alexis Thompson, MD
TWITCH:  TCD with Transfusions Changing to Hydroxyurea  Alexis Thompson, MD
Biomarkers of endothelial damage and repair in children with sickle cell anemia undergoing exercise testing- A pilot study  Alexis Thompson, MD
   
 Thrombosis and Clotting Disorders   Investigator 
 Warfarin Pharmacogenetics in Pediatric Patients  Alexis Thompson, MD

A Pilot & Feasibility Study to Examine the Safety and Efficacy of Flexitouch® Pneumatic Compression Device for the Treatment of Chronic Venous Insufficiency in Children with Previous History of Deep Venous Thrombosis 

 Anjali Sharathkumar, MD 

Global Evaluation of Post-thrombotic Syndrome in Children with Extremity Venous Thromboembolism (VTE): A Pilot & Feasibility Study 

 Anjali Sharathkumar, MD
   
Thalassemia  Investigator 
Thalassemia Data Collection (CDC) Alexis Thompson, MD
Thalassemia Longitudinal Cohort (TLC)   Alexis Thompson, MD
Thalassemia Knowledge and Attitudes Toward Trait Screening in At Risk Asian and Asian Indian Adults in Chicago: A Qualitative Study  Robert Liem, MD
 Novartis 2411 Registry Trial   Alexis Thompson, MD
 Novartis US 2209 “A One-Year Open Label Extension Phase II Extension of a Phase II Study of Deferasirox in Non-Transfusion Dependent Thalassemia Intermedia Patient”  Alexis Thompson, MD